News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zecotek Photonics Inc. Initiates Program to Improve Market Liquidity



3/29/2010 11:12:44 AM

SINGAPORE, SINGAPORE--(Marketwire - March 26, 2010) - Zecotek Photonics Inc. (TSX VENTURE: ZMS)(FRANKFURT: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it is initiating a Market Liquidity Program (more commonly known as market-making) managed by the Calgary office of CHF Investor Relations, its investor relations firm.

Further to the Company's previous announcement regarding the engagement of CHF's services (dated August 7, 2009), Zecotek Holdings Inc., a significant shareholder that is controlled by Zecotek's Chairman and CEO, Dr. A. F. Zerrouk, has furnished share capital for the purposes of market-making. The market-making activity will be conducted using a registered broker, in compliance with the guidelines established by the TSX Venture Exchange Policy 3.4 and other relevant policies, so that trading orders in Zecotek's shares are made to manage volatility and improve liquidity.

About CHF Investor Relations

CHF's is an outsourced, low-cost equivalent to an internal investor relations department for its client companies. CHF serves an international portfolio of TSX/TSX Venture listed companies and others that may seek to list on North American Exchanges that operate in a broad range of industries including high-tech, mining exploration and producers, oil & gas, industrial and business solutions and products, and "green" companies. The depth of capital market experience is formidable dating back to the late 1970's. CHF's head office is in Toronto with another Canadian office in Calgary as well as branch offices in New York, USA; Sao Paulo, Brazil; and Shanghai, China.

If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.

Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada (IIROC) accepts responsibility for the adequacy or accuracy of this release.


Contacts:
Zecotek Photonics Inc.
Michael Minder
(604) 827-5212
ir@zecotek.com

CHF Investor Relations
Christopher Haldane
Account Manager
(416) 868-1079 x237
chris@chfir.com
www.zecotek.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES